Bill Anderson, Roche’s current pharma CEO and former Genentech CEO will be leaving Roche at the end of 2022. Anderson has been in his current role since 2019 and is leaving to “pursue other opportunities.”
Thomas Schinecker, who is slated to become Roche’s new CEO in March will take over as Pharma CEO until a replacement is found.
Click here to read the entire article